Cargando…
BCPA {N,N′-1,4-Butanediylbis[3-(2-chlorophenyl)acrylamide]} Inhibits Osteoclast Differentiation through Increased Retention of Peptidyl-Prolyl cis-trans Isomerase Never in Mitosis A-Interacting 1
Osteoporosis is caused by an imbalance of osteoclast and osteoblast activities and it is characterized by enhanced osteoclast formation and function. Peptidyl-prolyl cis-trans isomerase never in mitosis A (NIMA)-interacting 1 (Pin1) is a key mediator of osteoclast cell-cell fusion via suppression of...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275020/ https://www.ncbi.nlm.nih.gov/pubmed/30388885 http://dx.doi.org/10.3390/ijms19113436 |
_version_ | 1783377743179677696 |
---|---|
author | Cho, Eugene Lee, Jin-Kyung Lee, Jee-Young Chen, Zhihao Ahn, Sun-Hee Kim, Nam Doo Kook, Min-Suk Min, Sang Hyun Park, Byung-Ju Lee, Tae-Hoon |
author_facet | Cho, Eugene Lee, Jin-Kyung Lee, Jee-Young Chen, Zhihao Ahn, Sun-Hee Kim, Nam Doo Kook, Min-Suk Min, Sang Hyun Park, Byung-Ju Lee, Tae-Hoon |
author_sort | Cho, Eugene |
collection | PubMed |
description | Osteoporosis is caused by an imbalance of osteoclast and osteoblast activities and it is characterized by enhanced osteoclast formation and function. Peptidyl-prolyl cis-trans isomerase never in mitosis A (NIMA)-interacting 1 (Pin1) is a key mediator of osteoclast cell-cell fusion via suppression of the dendritic cell-specific transmembrane protein (DC-STAMP). We found that N,N′-1,4-butanediylbis[3-(2-chlorophenyl)acrylamide] (BCPA) inhibited receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclastogenesis in a dose-dependent manner without cytotoxicity. In addition, BCPA attenuated the reduction of Pin1 protein during osteoclast differentiation without changing Pin1 mRNA levels. BCPA repressed the expression of osteoclast-related genes, such as DC-STAMP and osteoclast-associated receptor (OSCAR), without altering the mRNA expression of nuclear factor of activated T cells (NFATc1) and cellular oncogene fos (c-Fos). Furthermore, Tartrate-resistant acid phosphatase (TRAP)-positive mononuclear cells were significantly decreased by BCPA treatment compared to treatment with the Pin1 inhibitor juglone. These data suggest that BCPA can inhibit osteoclastogenesis by regulating the expression of the DC-STAMP osteoclast fusion protein by attenuating Pin1 reduction. Therefore, BCPA may be used to treat osteoporosis. |
format | Online Article Text |
id | pubmed-6275020 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62750202018-12-15 BCPA {N,N′-1,4-Butanediylbis[3-(2-chlorophenyl)acrylamide]} Inhibits Osteoclast Differentiation through Increased Retention of Peptidyl-Prolyl cis-trans Isomerase Never in Mitosis A-Interacting 1 Cho, Eugene Lee, Jin-Kyung Lee, Jee-Young Chen, Zhihao Ahn, Sun-Hee Kim, Nam Doo Kook, Min-Suk Min, Sang Hyun Park, Byung-Ju Lee, Tae-Hoon Int J Mol Sci Article Osteoporosis is caused by an imbalance of osteoclast and osteoblast activities and it is characterized by enhanced osteoclast formation and function. Peptidyl-prolyl cis-trans isomerase never in mitosis A (NIMA)-interacting 1 (Pin1) is a key mediator of osteoclast cell-cell fusion via suppression of the dendritic cell-specific transmembrane protein (DC-STAMP). We found that N,N′-1,4-butanediylbis[3-(2-chlorophenyl)acrylamide] (BCPA) inhibited receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclastogenesis in a dose-dependent manner without cytotoxicity. In addition, BCPA attenuated the reduction of Pin1 protein during osteoclast differentiation without changing Pin1 mRNA levels. BCPA repressed the expression of osteoclast-related genes, such as DC-STAMP and osteoclast-associated receptor (OSCAR), without altering the mRNA expression of nuclear factor of activated T cells (NFATc1) and cellular oncogene fos (c-Fos). Furthermore, Tartrate-resistant acid phosphatase (TRAP)-positive mononuclear cells were significantly decreased by BCPA treatment compared to treatment with the Pin1 inhibitor juglone. These data suggest that BCPA can inhibit osteoclastogenesis by regulating the expression of the DC-STAMP osteoclast fusion protein by attenuating Pin1 reduction. Therefore, BCPA may be used to treat osteoporosis. MDPI 2018-11-01 /pmc/articles/PMC6275020/ /pubmed/30388885 http://dx.doi.org/10.3390/ijms19113436 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Cho, Eugene Lee, Jin-Kyung Lee, Jee-Young Chen, Zhihao Ahn, Sun-Hee Kim, Nam Doo Kook, Min-Suk Min, Sang Hyun Park, Byung-Ju Lee, Tae-Hoon BCPA {N,N′-1,4-Butanediylbis[3-(2-chlorophenyl)acrylamide]} Inhibits Osteoclast Differentiation through Increased Retention of Peptidyl-Prolyl cis-trans Isomerase Never in Mitosis A-Interacting 1 |
title | BCPA {N,N′-1,4-Butanediylbis[3-(2-chlorophenyl)acrylamide]} Inhibits Osteoclast Differentiation through Increased Retention of Peptidyl-Prolyl cis-trans Isomerase Never in Mitosis A-Interacting 1 |
title_full | BCPA {N,N′-1,4-Butanediylbis[3-(2-chlorophenyl)acrylamide]} Inhibits Osteoclast Differentiation through Increased Retention of Peptidyl-Prolyl cis-trans Isomerase Never in Mitosis A-Interacting 1 |
title_fullStr | BCPA {N,N′-1,4-Butanediylbis[3-(2-chlorophenyl)acrylamide]} Inhibits Osteoclast Differentiation through Increased Retention of Peptidyl-Prolyl cis-trans Isomerase Never in Mitosis A-Interacting 1 |
title_full_unstemmed | BCPA {N,N′-1,4-Butanediylbis[3-(2-chlorophenyl)acrylamide]} Inhibits Osteoclast Differentiation through Increased Retention of Peptidyl-Prolyl cis-trans Isomerase Never in Mitosis A-Interacting 1 |
title_short | BCPA {N,N′-1,4-Butanediylbis[3-(2-chlorophenyl)acrylamide]} Inhibits Osteoclast Differentiation through Increased Retention of Peptidyl-Prolyl cis-trans Isomerase Never in Mitosis A-Interacting 1 |
title_sort | bcpa {n,n′-1,4-butanediylbis[3-(2-chlorophenyl)acrylamide]} inhibits osteoclast differentiation through increased retention of peptidyl-prolyl cis-trans isomerase never in mitosis a-interacting 1 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275020/ https://www.ncbi.nlm.nih.gov/pubmed/30388885 http://dx.doi.org/10.3390/ijms19113436 |
work_keys_str_mv | AT choeugene bcpann14butanediylbis32chlorophenylacrylamideinhibitsosteoclastdifferentiationthroughincreasedretentionofpeptidylprolylcistransisomeraseneverinmitosisainteracting1 AT leejinkyung bcpann14butanediylbis32chlorophenylacrylamideinhibitsosteoclastdifferentiationthroughincreasedretentionofpeptidylprolylcistransisomeraseneverinmitosisainteracting1 AT leejeeyoung bcpann14butanediylbis32chlorophenylacrylamideinhibitsosteoclastdifferentiationthroughincreasedretentionofpeptidylprolylcistransisomeraseneverinmitosisainteracting1 AT chenzhihao bcpann14butanediylbis32chlorophenylacrylamideinhibitsosteoclastdifferentiationthroughincreasedretentionofpeptidylprolylcistransisomeraseneverinmitosisainteracting1 AT ahnsunhee bcpann14butanediylbis32chlorophenylacrylamideinhibitsosteoclastdifferentiationthroughincreasedretentionofpeptidylprolylcistransisomeraseneverinmitosisainteracting1 AT kimnamdoo bcpann14butanediylbis32chlorophenylacrylamideinhibitsosteoclastdifferentiationthroughincreasedretentionofpeptidylprolylcistransisomeraseneverinmitosisainteracting1 AT kookminsuk bcpann14butanediylbis32chlorophenylacrylamideinhibitsosteoclastdifferentiationthroughincreasedretentionofpeptidylprolylcistransisomeraseneverinmitosisainteracting1 AT minsanghyun bcpann14butanediylbis32chlorophenylacrylamideinhibitsosteoclastdifferentiationthroughincreasedretentionofpeptidylprolylcistransisomeraseneverinmitosisainteracting1 AT parkbyungju bcpann14butanediylbis32chlorophenylacrylamideinhibitsosteoclastdifferentiationthroughincreasedretentionofpeptidylprolylcistransisomeraseneverinmitosisainteracting1 AT leetaehoon bcpann14butanediylbis32chlorophenylacrylamideinhibitsosteoclastdifferentiationthroughincreasedretentionofpeptidylprolylcistransisomeraseneverinmitosisainteracting1 |